Beyond ‘cure’ and ‘treatment success’: quality of life of patients with multidrug-resistant tuberculosis

This study is set in 2 drug-resistant tuberculosis (DR-TB) sites (MSF Clinic, Jupiter Hospital) in Mumbai, India

Abstract

This study is set in 2 drug-resistant tuberculosis (DR-TB) sites (MSF Clinic, Jupiter Hospital) in Mumbai, India. It aims to assess health-related quality of life (HRQoL) and associated factors among DR-TB patients and explore their perspectives about HRQoL.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Laxmeshwar C, Stewart AG, Dalal A, Kumar AMV, Kalaiselvi S, Das M, Gawde N, Thi SS, Isaakidis P. Beyond ‘cure’ and ‘treatment success’: quality of life of patients with multidrug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 2019;23(1):73–81.

Beyond ‘cure’ and ‘treatment success’: quality of life of patients with multidrug-resistant tuberculosis

Published 1 January 2019